SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-164171
Filing Date
2018-05-15
Accepted
2018-05-15 16:31:54
Documents
72
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d575889d10q.htm 10-Q 379275
2 EX-31.1 d575889dex311.htm EX-31.1 9941
3 EX-31.2 d575889dex312.htm EX-31.2 9921
4 EX-32.1 d575889dex321.htm EX-32.1 4089
5 EX-32.2 d575889dex322.htm EX-32.2 4301
  Complete submission text file 0001193125-18-164171.txt   3407978

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alt-20180331.xml EX-101.INS 496466
7 XBRL TAXONOMY EXTENSION SCHEMA alt-20180331.xsd EX-101.SCH 44378
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20180331_cal.xml EX-101.CAL 78696
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20180331_def.xml EX-101.DEF 205190
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20180331_lab.xml EX-101.LAB 409505
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20180331_pre.xml EX-101.PRE 303788
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 18837060
SIC: 2834 Pharmaceutical Preparations